First-generation  	First-generation  	 JJ	B-NP
antipsychotic  	antipsychotic  	 JJ	I-NP
long-acting  	long-acting  	 JJ	I-NP
injections  	injections  	 NNS	I-NP
v.  	v.  	 CC	O
oral  	oral  	 JJ	B-NP
antipsychotics  	antipsychotics  	 NN	I-NP
in  	in  	 IN	O
schizophrenia 	schizophrenia 	 NN	O
:  	:  	 :	O
systematic  	systematic  	 JJ	B-NP
review  	review  	 NN	I-NP
of  	of  	 IN	I-NP
randomised  	randomised  	 JJ	I-NP
controlled  	controlled  	 JJ	I-NP
trials  	trials  	 NNS	I-NP
and  	and  	 CC	O
observational  	observational  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
Antipsychotic  	Antipsychotic  	 JJ	I-NP
long-acting  	long-acting  	 JJ	I-NP
injections  	injections  	 NNS	I-NP
( 	( 	 -LRB-	O
LAIs 	LAIs 	 NNP	B-NP
)  	)  	 -RRB-	O
are  	are  	 VBP	O
often  	often  	 RB	O
used  	used  	 VBN	O
in  	in  	 IN	O
an  	an  	 DT	O
attempt  	attempt  	 NN	O
to  	to  	 TO	O
improve  	improve  	 VB	O
medication  	medication  	 JJ	B-NP
adherence  	adherence  	 NN	I-NP
in  	in  	 IN	O
people  	people  	 NNS	O
with  	with  	 IN	O
schizophrenia 	schizophrenia 	 NN	O
.  	.  	 .	O
To  	To  	 TO	O
compare  	compare  	 VB	O
first-generation  	first-generation  	 JJ	B-NP
antipsychotic  	antipsychotic  	 JJ	I-NP
long-acting  	long-acting  	 JJ	I-NP
injections  	injections  	 NNS	I-NP
( 	( 	 -LRB-	O
FGA-LAIs 	FGA-LAIs 	 NNP	B-NP
)  	)  	 -RRB-	O
with  	with  	 IN	O
first-  	first-  	 JJ	O
and  	and  	 CC	O
second-generation  	second-generation  	 JJ	B-NP
oral  	oral  	 JJ	I-NP
antipsychotics  	antipsychotics  	 NN	I-NP
in  	in  	 IN	O
terms  	terms  	 NNS	O
of  	of  	 IN	O
clinical  	clinical  	 JJ	B-NP
outcome 	outcome 	 NN	I-NP
.  	.  	 .	O
Systematic  	Systematic  	 JJ	B-NP
literature  	literature  	 NN	I-NP
review 	review 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
meta-analysis  	meta-analysis  	 JJ	B-NP
of  	of  	 IN	I-NP
randomised  	randomised  	 JJ	I-NP
controlled  	controlled  	 JJ	I-NP
trials  	trials  	 NNS	I-NP
( 	( 	 -LRB-	O
RCTs 	RCTs 	 NNP	B-NP
)  	)  	 -RRB-	O
showed  	showed  	 VBD	O
no  	no  	 DT	O
difference  	difference  	 NN	O
in  	in  	 IN	O
relapse  	relapse  	 NN	O
or  	or  	 CC	O
tolerability  	tolerability  	 NN	B-NP
between  	between  	 IN	O
oral  	oral  	 JJ	B-NP
antipsychotics  	antipsychotics  	 NN	I-NP
and  	and  	 CC	O
FGA-LAIs  	FGA-LAIs  	 JJ	B-NP
but  	but  	 CC	O
global  	global  	 JJ	O
improvement  	improvement  	 NN	O
was  	was  	 VBD	O
twice  	twice  	 RB	O
as  	as  	 IN	O
likely  	likely  	 JJ	O
with  	with  	 IN	O
FGA-LAIs 	FGA-LAIs 	 JJ	B-NP
.  	.  	 .	O
Four  	Four  	 CD	O
prospective  	prospective  	 JJ	B-NP
observational  	observational  	 JJ	I-NP
studies  	studies  	 NNS	I-NP
were  	were  	 VBD	O
identified 	identified 	 VBN	O
;  	;  	 :	O
two  	two  	 CD	O
studies  	studies  	 NNS	O
reported  	reported  	 VBD	O
lower  	lower  	 JJR	O
discontinuation  	discontinuation  	 NN	B-NP
rates  	rates  	 NNS	I-NP
for  	for  	 IN	I-NP
FGA-LAIs  	FGA-LAIs  	 JJ	I-NP
compared  	compared  	 VBN	O
with  	with  	 IN	O
oral  	oral  	 JJ	B-NP
medication  	medication  	 NN	I-NP
and  	and  	 CC	O
two  	two  	 CD	O
found  	found  	 VBD	O
that  	that  	 DT	O
outcome  	outcome  	 NN	O
was  	was  	 VBD	O
either  	either  	 RB	O
no  	no  	 DT	O
different  	different  	 JJ	O
or  	or  	 CC	O
better  	better  	 JJR	O
with  	with  	 IN	O
oral  	oral  	 JJ	B-NP
antipsychotics 	antipsychotics 	 NN	I-NP
.  	.  	 .	O
Mirror-image  	Mirror-image  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
consistently  	consistently  	 RB	O
showed  	showed  	 VBD	O
reduced  	reduced  	 VBN	O
in-patient  	in-patient  	 JJ	O
days  	days  	 NNS	O
and  	and  	 CC	O
admissions  	admissions  	 NNS	O
following  	following  	 VBG	O
a  	a  	 DT	O
switch  	switch  	 NN	O
from  	from  	 IN	O
oral  	oral  	 JJ	B-NP
antipsychotics  	antipsychotics  	 NN	I-NP
to  	to  	 TO	O
FGA-LAIs 	FGA-LAIs 	 JJ	B-NP
.  	.  	 .	O
The  	The  	 DT	O
results  	results  	 NNS	O
are  	are  	 VBP	O
variable  	variable  	 JJ	O
and  	and  	 CC	O
inconclusive 	inconclusive 	 JJ	O
.  	.  	 .	O
Some  	Some  	 DT	O
evidence  	evidence  	 NN	O
suggests  	suggests  	 VBZ	O
that  	that  	 DT	O
FGA-LAIs  	FGA-LAIs  	 NN	B-NP
may  	may  	 MD	O
improve  	improve  	 VB	O
outcome  	outcome  	 NN	O
compared  	compared  	 VBN	O
with  	with  	 IN	O
oral  	oral  	 JJ	B-NP
antipsychotics 	antipsychotics 	 NN	I-NP
.  	.  	 .	O
Methodological  	Methodological  	 JJ	B-NP
issues  	issues  	 NNS	I-NP
may  	may  	 MD	O
partly  	partly  	 RB	O
explain  	explain  	 VB	O
the  	the  	 DT	O
variable  	variable  	 JJ	O
results 	results 	 NNS	O
.  	.  	 .	O
Selective  	Selective  	 JJ	B-NP
recruitment  	recruitment  	 NN	I-NP
in  	in  	 IN	O
RCTs  	RCTs  	 JJ	O
and  	and  	 CC	O
lack  	lack  	 NN	O
of  	of  	 IN	O
randomisation  	randomisation  	 NN	B-NP
in  	in  	 IN	O
observational  	observational  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
are  	are  	 VBP	O
biases  	biases  	 VBN	O
against  	against  	 IN	O
LAIs 	LAIs 	 NNP	B-NP
,  	,  	 ,	O
whereas  	whereas  	 IN	O
regression  	regression  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
mean  	mean  	 NN	B-NP
in  	in  	 IN	O
mirror-image  	mirror-image  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
favours  	favours  	 VBP	O
LAIs 	LAIs 	 JJ	B-NP
.  	.  	 .	O
In  	In  	 IN	O
terms  	terms  	 NNS	O
of  	of  	 IN	O
future  	future  	 JJ	O
research 	research 	 NN	O
,  	,  	 ,	O
a  	a  	 DT	O
long-term  	long-term  	 JJ	O
pragmatic  	pragmatic  	 JJ	B-NP
RCT  	RCT  	 NN	I-NP
of  	of  	 IN	O
an  	an  	 DT	O
FGA-LAI  	FGA-LAI  	 JJ	B-NP
against  	against  	 IN	O
an  	an  	 DT	O
oral  	oral  	 JJ	B-NP
antipsychotic 	antipsychotic 	 NN	I-NP
,  	,  	 ,	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
problematic  	problematic  	 JJ	B-NP
adherence 	adherence 	 NN	I-NP
,  	,  	 ,	O
would  	would  	 MD	O
be  	be  	 VB	O
of  	of  	 IN	O
value 	value 	 NN	O
.  	.  	 .	O
